Global Electronic Trial Master File (eTMF) Systems Market to reach USD 2.5 billion by 2027.
Global Electronic Trial Master File (eTMF) Systems Market is valued approximately at USD 1.1 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 12.7% over the forecast period 2021-2027. Electronic trial master file (eTMF) systems are a collection of software and hardware components that work together to ensure that clinical trial data is managed as efficiently as possible. These solutions facilitate faster data generated during the course of a clinical trial into an easy-to-store digital format that can be retrieved by a variety of users, resulting in improved accessibility and a reduction in cost of administrative and manual data regular maintenance in clinical trials. eTMF systems market is driven by rising government funding and grants to support clinical trials and rising adoption of eTMF systems in the upcoming years. For instance, according to the European Medicines Agency, 37,293 clinical trials are presently registered in Europe (as of 2020). Furthermore, rise in R&D investment in various regions such as North America and Europe. For instance, according to the Pharmaceutical Researchers and Manufacturers of America (PhRMA), the United States has the highest R&D expenditure share of about 58 percent. Furthermore, according to the same source, biopharmaceutical businesses spent about USD 79.6 billion on R&D in the United States. However, budget constraints may impede market growth over the forecast period of 2021-2027.

Geographically, North America held the largest share of the market. Increased government support for clinical research, a high number of clinical trials, and the presence of many big competitors in the US are all factors contributing to North America's large market share. However, Asia Pacific also is expected to contribute to the global electronic trial master file market's growth. The pharmaceutical industry's advancements are responsible for this growth. India and China are two key Nations working to grow their pharmaceutical companies.

Major market player included in this report are:
Aurea Software
Veeva Systems
Wingspan Technology
Epharma solutions
Mastercontrol, Inc.
Oracle Corporation
Laboratory Corporation of America Holdings
TransPerfect, Translation company
SureClinical Inc
Phlexglobal Ltd




The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Delivery Mode:
Cloud-based eTMF
On-premise eTMF
By Components:
Services
Software
By End user:
Pharmaceutical & biotechnology companies
Contract Research Organizations (CROs)
Other end-users
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019
Base year - 2020
Forecast period - 2021 to 2027.

Target Audience of the Global Electronic Trial Master File (eTMF) Systems Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors